TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

Pfizer

PFE
OncologyInfectious DiseaseDermatology
Big Pharma

Global pharmaceutical leader with blockbuster franchises in vaccines (Prevnar, Comirnaty), cardiovascular (Eliquis), and oncology. Known for rapid COVID-19 vaccine development and strategic acquisitions including Seagen.

$58.5B
Revenue (2024)
$145.0B
Market Cap
-
Trials
1427
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 40%
28 drugs Phase 3: 47 Phase 2: 44 Phase 1: 119
Infectious Disease 22%
27 drugs Phase 3: 15 Phase 2: 37 Phase 1: 18
Dermatology 16%
18 drugs Phase 3: 18 Phase 2: 16 Phase 1: 14
Immunology 12%
11 drugs Phase 3: 15 Phase 2: 18 Phase 1: 6
Gastroenterology 11%
15 drugs Phase 3: 5 Phase 2: 9 Phase 1: 23

Pipeline Strength Pro

Loading...